Series A Milestone Lin Health has just secured an $11M Series A round led by Proofpoint Capital with participation from .406 Ventures and Activate Capital, signaling strong investor confidence and potential for scaled partnerships with payers and health systems seeking non-opioid chronic pain solutions.

Non-Opioid Solution The company focuses on non-pharmacological, neuroscience‑driven chronic pain treatment, presenting a compelling value proposition for payers and providers aiming to reduce opioid usage and associated costs.

Tech Enabled Care With a proprietary AI based care platform and telehealth capabilities, Lin Health offers scalable, personalized care that can integrate into existing clinic workflows, creating opportunities for digital health integrations and co‑development with health systems.

Growth Focus Recent funding and growth in telehealth and digital behavioral health for chronic pain indicates expansion opportunities across health systems, clinics, and payers seeking scalable pain management programs.

Recognition & Reach Industry recognition such as Consumer Wellness Rising Star and a published telehealth platform launch highlight market credibility and potential to accelerate partnerships with large health networks seeking innovative patient engagement platforms.